NEVVI Medicare utilization intelligence

← back

ARROWSMITH, EDWARDMD NPI 1780632687 Clinician

Hematology-Oncology · CHATTANOOGA, TN

Specialty Hematology-Oncology — from billed Medicare claims
Trained VANDERBILT UNIVERSITY SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 26 years since medical school (class of 2000, self-reported to CMS)
Location CHATTANOOGA, TN · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 64 codes billed · 67,073 disclosed volume (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
TENNESSEE ONCOLOGY PLLC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2013-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed submitted charges across all codes were in CY2024. Included with Platform.

  • Charge, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1437 Injection, ferric derisomaltose, 10 mg
80053 Blood test, comprehensive group of blood chemicals
J0897 Injection, denosumab, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
82728 Ferritin (blood protein) level
J1100 Injection, dexamethasone sodium phosphate, 1 mg
83540 Iron level
83550 Iron binding capacity
82607 Cyanocobalamin (vitamin b-12) level
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
82746 Folic acid level, serum
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
83615 Lactate dehydrogenase (enzyme) level
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
84443 Blood test, thyroid stimulating hormone (tsh)
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J1626 Injection, granisetron hydrochloride, 100 mcg
84153 Psa (prostate specific antigen) measurement, total
84439 Thyroxine (thyroid chemical), free
83735 Magnesium level
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82533 Cortisol (hormone) measurement, total
96413 Administration of chemotherapy into vein, 1 hour or less
80048 Blood test, basic group of blood chemicals (calcium, total)
96372 Injection of drug or substance under skin or into muscle
82378 Carcinoembryonic antigen (cea) protein level
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
83521 Measurement of immunoglobulin light chains
96375 Injection of additional new drug or substance into vein
84550 Uric acid level, blood
84100 Phosphate level
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
82784 Gammaglobulin (immune system protein) measurement
A9596 Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
84165 Protein measurement, serum
J7030 Infusion, normal saline solution , 1000 cc
71260 Ct scan of chest with contrast
96361 Infusion into a vein for hydration, each additional hour
74177 Ct scan of abdomen and pelvis with contrast
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
96360 Infusion into a vein for hydration, 31-60 minutes
86334 Immunologic analysis technique on serum (immunofixation)
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96417 Administration of additional new drug or substance into vein, 1 hour or less
96523 Irrigation of implanted venous access drug delivery device
81003 Automated urinalysis test
J1200 Injection, diphenhydramine hcl, up to 50 mg
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96374 Injection of drug or substance into vein
G0008 Administration of influenza virus vaccine
90653 Influenza vaccine, inactivated
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
78816 Nuclear medicine study whole body with ct scan
71250 Ct scan of chest without contrast
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.